Immunologic Response to Influenza Vaccination in Children and Adolescents: A RCT Trial of Influenza Vaccines
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 14 Nov 2019
Price : $35 *
At a glance
- Drugs Influenza vaccine (Optaflu) (Primary) ; Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 01 May 2019 Status changed from recruiting to active, no longer recruiting.
- 05 Oct 2018 Status changed from not yet recruiting to recruiting.
- 08 Aug 2018 New trial record